Jupiter Neurosciences Statistics
Total Valuation
JUNS has a market cap or net worth of $41.66 million. The enterprise value is $41.11 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JUNS has 34.43 million shares outstanding. The number of shares has increased by 20.07% in one year.
| Current Share Class | 34.43M |
| Shares Outstanding | 34.43M |
| Shares Change (YoY) | +20.07% |
| Shares Change (QoQ) | +2.59% |
| Owned by Insiders (%) | 52.14% |
| Owned by Institutions (%) | 3.95% |
| Float | 16.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 31.37 |
| PB Ratio | 725.50 |
| P/TBV Ratio | 725.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 3.14.
| Current Ratio | 0.65 |
| Quick Ratio | 0.29 |
| Debt / Equity | 3.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -221.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -354.94% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -13,163.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.90M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 40.56 |
| Average Volume (20 Days) | 90,008 |
Short Selling Information
The latest short interest is 22,817, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 22,817 |
| Short Previous Month | 139,680 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.24M |
| Operating Income | -7.56M |
| Pretax Income | -7.60M |
| Net Income | -7.60M |
| EBITDA | n/a |
| EBIT | -7.56M |
| Earnings Per Share (EPS) | -$0.23 |
Full Income StatementBalance Sheet
The company has $723,797 in cash and $180,393 in debt, giving a net cash position of $543,404 or $0.02 per share.
| Cash & Cash Equivalents | 723,797 |
| Total Debt | 180,393 |
| Net Cash | 543,404 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 57,417 |
| Book Value Per Share | 0.00 |
| Working Capital | -886,484 |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.74M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
